Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

Overview of attention for article published in PLOS ONE, April 2010

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 177 Dimensions

Readers on

mendeley: 237 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Targeted TGFβ inhibition

Grant US-11370819-B2

United States of America

Method of reducing the number of EMT and MET type breast cancer stem cells

Grant US-9352039-B2

United States of America